Welcome to our dedicated page for Enhanced Group SEC filings (Ticker: ENHA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The ENHA SEC filings page on Stock Titan is designed to organize regulatory documents associated with Enhanced Group Inc. in connection with its proposed business combination with A Paradise Acquisition Corp. and anticipated Nasdaq listing under the ticker ENHA. While no filings are yet available under this symbol, future documents are expected to be filed with the U.S. Securities and Exchange Commission as the transaction progresses.
For a company like Enhanced, which is building a sports and performance medicine platform around the Enhanced Games, key filings are expected to include a registration statement on Form S-4 containing a proxy statement/prospectus for A Paradise shareholders. That document is intended to describe the terms of the business combination, the structure of the combined company, risk factors, and detailed information about Enhanced’s business model, including its live events, telehealth and direct-to-consumer offerings, brand partnerships, and media and broadcasting rights.
Once ENHA-related filings become available, this page will surface them in real time as they are posted to the SEC’s EDGAR system. Users will be able to review annual and quarterly reports, if and when they are filed, as well as current reports and other registration materials that describe developments in Enhanced’s operations, capital structure, and governance following the business combination.
Stock Titan’s platform enhances these documents with AI-powered summaries that explain the main points of lengthy filings in accessible language. This can be particularly useful for understanding complex transaction disclosures, performance medicine and telehealth business descriptions, and risk discussions. As ENHA’s regulatory history develops, this page will provide a structured view of the company’s filings, along with tools to quickly identify insider-related forms and other material updates.
Apeiron Investment Group Ltd. reported acquisition or exercise transactions in this Form 4 filing.
Apeiron Investment Group Ltd., as nominee for Enhanced Holdings LP, received 3,020,565 shares of Enhanced Group Inc. Class A Common Stock and 3,020,565 Warrants in the first tranche of a private placement at a combined purchase price of $3.89 per share and Warrant. The Warrants have a five-year term and may be accelerated if the stock trades at or above $20 for twenty consecutive trading days. After this issuance, entities associated with Christian Angermayer indirectly hold 32,712,812 Class A shares; he may be deemed to share beneficial ownership but disclaims it except for his pecuniary interest.
Apeiron Investment Group Ltd., Enhanced Holdings and Christian Angermayer report beneficial ownership of 35,945,876 shares of Enhanced Group Inc. Class A Common Stock, representing 26.6% of the class, including 32,712,812 shares and 3,233,064 shares underlying currently exercisable warrants, based on 131,677,754 shares outstanding.
On July 22, 2026, the first tranche of a previously disclosed Purchase Agreement closed, through which Apeiron received 3,020,565 Class A shares and accompanying warrants. The securities are held of record by Apeiron as nominee for Enhanced Holdings LP, with Angermayer able to share voting and dispositive power through affiliated entities while disclaiming beneficial ownership.
Enhanced Group Inc. is registering for resale by selling securityholders up to 6,426,733 shares of Class A common stock and up to 6,426,733 additional shares issuable upon exercise of outstanding PIPE Warrants. The company will not receive proceeds from these resales, but may receive cash if the PIPE Warrants, which currently carry a $3.89 per share exercise price subject to an Anti-Dilution Adjustment, are exercised for cash.
The resale shares stem from a June 2026 private placement of 12,853,468 shares of Class A common stock and accompanying warrants for approximately $50.0 million in expected gross proceeds, structured in three closings. The First Closing on June 17, 2026 generated about $25.0 million, part of which repaid an $11.75 million working capital note to Apeiron; a Second Closing for 3,020,565 shares and warrants is occurring in July 2026, while a Third Closing for 3,406,170 shares and warrants, tied to stockholder consent, remains pending.
Enhanced Group, a Texas-based growth-stage sports entertainment and performance technology company, operates the "Enhanced Games" and the "Live Enhanced" subscription wellness platform and became public via a reverse recapitalization with A Paradise, with its Class A common stock trading on NYSE under “ENHA.” Apeiron and affiliates hold more than 50% of voting power, making the company a NYSE “controlled company” and it also qualifies as an emerging growth and smaller reporting company. As of June 30, 2026, cash and cash equivalents were $19.6 million, and management discloses substantial doubt about the company’s ability to continue as a going concern without additional capital, including completion of the Third Closing, while significant warrant overhang and anti-dilution features may increase future dilution and resale pressure.
Enhanced Group Inc. obtained majority shareholder written consent to approve a private placement of 12,853,468 Class A shares together with 12,853,468 common warrants under a Securities Purchase Agreement. The combined purchase price is $3.89 per share and warrant, matching the NYSE closing price on June 12, 2026, for expected gross proceeds of about $50.0 million before fees.
The third and final tranche, representing approximately $13.25 million, will close after the 20‑day information statement waiting period and other conditions. Warrants are exercisable at $3.89 per share for up to five years, with price‑based acceleration and 24‑month anti‑dilution protection. Proceeds are or will be used to repay an approximately $11.75 million working capital note to Apeiron, with the note then terminated, and for working capital and growth of ENHA’s telehealth and consumer health platform.
Enhanced Holdings LP, through Apeiron, holds about 96.6% of voting power and gave the written consent, so no shareholder vote or meeting is required. Apeiron is investing approximately $20.0 million, and CEO Maximilian Martin is investing approximately $5.0 million, both on NYSE‑approved related‑party terms. Existing Class A holders will experience ownership and voting dilution if all shares and warrants are issued and exercised.
Enhanced Group Inc. is informing shareholders that on June 16, 2026 its controlling holder, Enhanced Holdings LP (acting through Apeiron), approved by written consent a private placement under a Securities Purchase Agreement to issue 12,853,468 newly issued Class A shares and accompanying common warrants to purchase 12,853,468 Class A shares at a combined purchase price of $3.89 per share and warrant. The Company expects gross proceeds of approximately $50.0 million (excluding any proceeds from future warrant exercises) and notes the third tranche represents about $13.25 million of aggregate gross proceeds and will close after the Written Consent becomes effective.
The Information Statement explains that Apeiron and the CEO, Maximilian Martin, are participating in the Private Placement, that the transaction satisfies NYSE shareholder-approval requirements, and that the issuance will dilute existing Class A holders if warrants are exercised. The Written Consent became effective after the statutory 20-calendar-day mailing period.
Enhanced Group Inc. supplements its Form S-1 prospectus with a Current Report on Form 8-K describing a private placement under a Securities Purchase Agreement to sell 12,853,468 shares of Class A common stock and accompanying warrants to purchase 12,853,468 shares. The combined purchase price per Share and accompanying Warrant is $3.89, producing expected gross proceeds of approximately $50.0 million.
The offering is expected to close in three tranches, with approximately $25.0 million at the First Closing (on or about June 17, 2026), approximately $11.75 million at the second closing (on or about June 22, 2026) and the remaining $13.25 million upon a later closing conditioned on stockholder consent. The Company expects to use part of the First Closing proceeds to repay a working capital promissory note and the remainder for working capital and corporate purposes.
Apeiron Investment Group Ltd., Enhanced Holdings and Christian Angermayer report significant ownership in Enhanced Group Inc. and commit to new funding. They beneficially own 29,904,746 shares of Class A common stock, representing 24.4% of the class, with shared voting and dispositive power.
On June 14, 2026, Enhanced Group agreed in a private placement to issue Apeiron 5,141,388 Class A shares and warrants for 5,141,388 additional shares at a combined price of $3.89 per share and accompanying warrant. The deal will close in two tranches and is supported by a registration rights agreement requiring the company to register the resale of these securities within set SEC timing windows.
Enhanced Group Inc. entered into a $50 million private PIPE financing, selling 12,853,468 Class A shares and 12,853,468 accompanying warrants at $3.89 per share and per warrant. The deal is led by controlling shareholder Apeiron Investment Group and includes CEO Maximilian Martin.
The financing will close in three tranches, with about $25 million expected around June 17, 2026 and the rest within roughly 45 days, subject to customary conditions. A portion of the first tranche will fully repay a working capital promissory note owed to Apeiron, with no prepayment penalty, and the remainder will support working capital and growth of Enhanced’s telehealth and consumer health platform.
The warrants carry a $3.89 exercise price, a five-year term (subject to an accelerated expiry if the stock trades at or above $20.00 for 20 consecutive days), anti-dilution adjustments for lower-priced equity financings in the first 24 months, and beneficial ownership caps generally at 4.99% or, at the holder’s election, up to 19.99%. Enhanced has agreed to register the resale of the shares and warrant shares after closing and to seek stockholder approval, via written consent from its controlling stockholder, for issuances that could exceed 19.99% of outstanding common stock or voting power.
Highbridge Capital Management filed a Schedule 13G disclosing beneficial ownership in Enhanced Group Inc. The filing states Highbridge may be deemed to beneficially own 1,722,744 Class A Ordinary Shares, representing 8.4% of the Class A Ordinary Shares outstanding as of March 31, 2026. The outstanding share base cited is 20,600,000 Class A Ordinary Shares as of February 9, 2026, per the issuer's 2025 Form 10-K. The statement notes holdings were directly held by Highbridge-managed funds and is presented as ownership information under Schedule 13G.
Apeiron Investment Group Ltd., Enhanced Holdings entities and Christian Angermayer report a significant stake in Enhanced Group Inc. They beneficially own 29,904,746 shares of Class A Common Stock, representing 24.4% of the class, including shares underlying currently exercisable warrants. This stake was received through a business combination in which Enhanced Ltd. became a wholly owned subsidiary of Enhanced Group Inc.
The reporting group also holds 258,837,933 shares of Class B Common Stock, which carry 10 votes per share but no dividend rights and are not convertible into Class A. Their Class A holdings are subject to lock-up and registration rights agreements, and 25,586,376 Class A shares are pledged as collateral under a loan agreement. Apeiron has deposited $5.5 million and holds put and call option rights over sponsor-held securities within specified price ranges for a 90-day period after closing.